NASDAQ: MBIO       Mustang Bio Inc
Last Price Today's Change   Day's Range   Trading Volume
3.85   +0.02 (0.52%)  3.60 - 3.95  899,500


Avg Volume (4 weeks):358,430
4 Weeks Range:2.51 - 3.96
4 Weeks Price Volatility (%):
52 Weeks Range:2.18 - 10.20
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Mustang Bio Inc is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of novel cancer immunotherapy products designed to utilize the power of the patient's own immune system to eliminate cancer cells. The company is currently developing its proprietary Chimeric Antigen Receptor (CAR) engineered T cells technology which is licensed from Dr. Stephen Forman's laboratory at the City of Hope National Medical Center (COH). Through a research agreement with COH, the company will develop CARs across multiple cancers, including for AML and Brain Cancer.

  Be the first to like this.


4706  3347  638  230 

Top 10 Active Counters
 CELG 108.24+0.11 
 GDX 26.97-0.65 
 CHK 0.76+0.041 
 EEM 43.07+0.25 
 BAC 33.67+0.58 
 GE 11.10+0.31 
 SPY 314.87+2.85 
 XOP 21.23+0.74 
 VIAB 24.22+0.75 
 ONTX 0.35+0.058 
Partners & Brokers